Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

China Pharma Holdings (CPHI)

China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

China Pharma Holdings Second Floor No. 17 Jinpan Road Haikou F4 570216 CHN

www.chinapharmaholdings.com Employees: 231 P: 86-898-6681-1730

Sector:

Medical

Description:

CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.

Key Statistics

Overview:

Market Capitalization, $K 6,780
Enterprise Value, $K 8,560
Shares Outstanding, K 5,022
Annual Sales, $ 4,530 K
Annual Net Income, $ -4,740 K
Last Quarter Sales, $ 760 K
Last Quarter Net Income, $ -650 K
EBIT, $ -3,240 K
EBITDA, $ -620 K
60-Month Beta 1.03
% of Insider Shareholders 6.40%
% of Institutional Shareholders 0.00%
Float, K 4,701
% Float 93.60%
Short Interest 8
Short Float 0.17%
Short Volume Ratio 0.34

Growth:

1-Year Return -27.05%
3-Year Return -97.63%
5-Year Return -99.60%
5-Year Revenue Growth -58.52%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.17 on 11/12/25
Next Earnings Date 02/11/26
Earnings Per Share ttm -0.57
EPS Growth vs. Prev Qtr -6.25%
EPS Growth vs. Prev Year 71.67%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 04/15/25

CPHI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -41.54%
Return-on-Assets % -21.30%
Profit Margin % -104.64%
Debt/Equity 0.24
Price/Sales 1.06
Price/Cash Flow N/A
Price/Book 0.78
Book Value/Share 1.66
Interest Coverage -30.60
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar